Financial Performance - Revenue for the three months ended March 31, 2025, was $36.7 million, representing a 3% increase from $35.6 million in the same period of 2024[123] - Net loss for the three months ended March 31, 2025, was $11.4 million, compared to a net loss of $10.6 million for the same period in 2024[124] - Adjusted EBITDA for the three months ended March 31, 2025, was $(5.1) million, slightly improved from $(5.2) million in the same period of 2024[125] - Total revenue for the three months ended March 31, 2025, was $36,653,000, representing a 3% increase from $35,571,000 in the same period of 2024[153] - Net loss attributable to common stockholders was $11,393,000 for the three months ended March 31, 2025, compared to a loss of $10,582,000 in 2024[150] - Adjusted EBITDA for the three months ended March 31, 2025, was $(5,089,000), slightly improved from $(5,192,000) in the same period of 2024[163] Revenue Composition - Usage-based revenue accounted for 90% of total revenue for the three months ended March 31, 2025, while subscription revenue represented 10%[142] - Revenue from new customers added since March 31, 2024, contributed $4,500,000, offset by a $3,400,000 decrease in revenue from existing customers[153] Cash and Investments - As of March 31, 2025, the company had $34.5 million in cash and cash equivalents and $84.3 million in short-term investments[123] - As of March 31, 2025, the company had cash and cash equivalents of $34,500,000 and short-term investments of $84,300,000, sufficient to fund anticipated cash requirements for the next 12 months[164] - Significant purchases of short-term investments amounted to $45.4 million in Q1 2025, partially offset by $38.3 million in maturities of investments[172] Operating Expenses - Cost of revenue increased by $651,000, or 7%, to $9,503,000, with cloud hosting costs rising by $400,000 due to increased usage[156] - Research and development expenses rose by $2,178,000, or 18%, totaling $14,257,000, primarily due to increased personnel costs[157] - Sales and marketing expenses decreased by $1,281,000, or 8%, to $14,527,000, attributed to reduced headcount and marketing expenses[158] - General and administrative expenses decreased by $188,000, or 2%, to $10,976,000, mainly due to lower professional services and insurance costs[159] Cash Flow - Net cash used in operating activities for Q1 2025 was $10.5 million, an increase of $3.2 million from $7.3 million in Q1 2024, representing a 43% increase[170] - Cash used in investing activities for Q1 2025 was $7.7 million, an increase of $7.0 million from $0.7 million in Q1 2024, indicating a significant rise in investment expenditures[171] - Cash used in financing activities decreased to $0.1 million in Q1 2025, down by $2.8 million from $2.9 million in Q1 2024, a reduction of 97%[173] - The net decrease in cash and cash equivalents for Q1 2025 was $18.2 million, a 68% increase compared to $10.9 million in Q1 2024[168] - The increase in cash flow used in operations was partially due to a net loss increase of $0.8 million and a decrease of $1.7 million in accounts receivable[170] Strategic Initiatives - The company plans to expand its international customer base, particularly in the United Kingdom and India, where less than 10% of revenue was generated from customers outside the United States[138] - The company intends to continue pursuing strategic acquisitions and investments to enhance its product offerings and bring in talent[139] - The launch of the ediscovery chatbot, Cecilia, occurred in Q4 2023 in the United States and Q3 2024 in Europe, showcasing the company's commitment to innovation[130] - The company aims to increase sales coverage by enhancing its sales force headcount in strategic locations across the United States and globally[135] Economic Factors - Macroeconomic conditions, including inflation and geopolitical events, may negatively impact the company's growth and results of operations[126] Financing and Accounting - The company may seek additional equity or debt financing in the future to support growth and innovation[167] - The company has historically generated negative cash flows and supplemented working capital primarily through equity securities sales[169] - The company capitalizes certain software development costs, which are amortized over an estimated useful life of four years[176] - Acquisitions involve significant estimates and assumptions regarding the fair value of intangible assets, which may lead to adjustments in future periods[177] - The company has opted not to use the extended transition period for complying with new accounting standards as an emerging growth company[179]

DISCO Announces First Quarter 2025 Financial Results Total Revenue of $36.7 Million, A Year over Year Increase of 3% AUSTIN, Texas - May 7, 2025 - CS Disco, Inc. ("DISCO") (NYSE: LAW) today announced financial results for its first quarter ended March 31, 2025. "At DISCO, we are shaping the future of litigation and believe our industry-leading platform equips legal teams with tools not previously available to the legal world," said Eric Friedrichsen, DISCO Chief Executive Officer. "We are enabling customers ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”); (2) held shares of Cerevel as of the January 8, 2024 record date and were entitled to vote on the merger of Cerevel and AbbVie Inc.; and/or (3) sold shares of Cer ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of enCore Energy Corp. (NASDAQ: EU) between March 28, 2024 and March 2, 2025, both dates inclusive (the “Class Period”), of the important May 13, 2025 lead plaintiff deadline. SO WHAT: If you purchased enCore securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO D ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time and has consistently ranked highly in securities class action settlements [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]

Core Viewpoint - A class action lawsuit has been filed against Open Lending Corporation for allegedly making materially false and misleading statements regarding its business operations and financial performance during the class period from February 24, 2022, to March 31, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Open Lending's defendants misrepresented the capabilities of its risk-based pricing models and issued misleading statements about profit share revenue [5]. - It is alleged that Open Lending's 2021 and 2022 vintage loans were worth significantly less than their outstanding loan balances, and that the underperformance of the 2023 and 2024 vintage loans was misrepresented [5]. - The lawsuit asserts that these misleading statements led to investor damages when the true details about Open Lending's business were revealed [5]. Group 2: Participation Information - Investors who purchased Open Lending securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm for more information [3]. - A lead plaintiff must move the Court by June 30, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 alone [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4]. - The firm emphasizes the importance of selecting qualified counsel with a proven history in leadership roles within class action lawsuits [4].

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NET Power Inc. (NYSE: NPWR, NPWR.WS) between June 9, 2023 and March 7, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 17, 2025. SO WHAT: If you purchased NET Power securities during the Class Period you may be entitled to compensation without p ...

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Perpetua Resources Corp. during the specified Class Period of the upcoming lead plaintiff deadline on May 20, 2025 [1]. Group 1: Class Action Details - Investors who purchased Perpetua securities between April 17, 2024, and February 13, 2025, may be entitled to compensation through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lead plaintiff must file a motion with the Court by May 20, 2025, to represent other class members [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]. Group 3: Case Specifics - The lawsuit alleges that during the Class Period, Perpetua's Defendants provided misleading information regarding the expected initial capital expenditure for the Stibnite Gold Project, downplaying inflation's impact [5]. - Defendants allegedly concealed material adverse facts about the true costs of the project, leading to artificially inflated security prices for investors [5]. - When the true details were revealed, investors reportedly suffered damages due to the misleading statements made by the Defendants [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Sana Biotechnology, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on May 20, 2025, for a class action lawsuit [1][2] Group 1: Class Action Details - Investors who bought Sana securities between March 17, 2023, and November 4, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by May 20, 2025 [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] Group 3: Case Allegations - The lawsuit alleges that during the Class Period, Sana made false or misleading statements regarding its financial health and the potential of its product candidates, including SC291, SC379, and SG299 [4] - It is claimed that Sana was at significant risk of insufficient funds to maintain operations and that the company overstated its financial capacity [4]